WebOct 11, 2024 · SAN CARLOS, Calif., Oct. 11, 2024 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (NASDAQ:CCXI), today announced the appointment of Rita I. Jain, M.D., as Executive... WebDr. Jain joined the board of directors in January 2024 and is a Board Certified Rheumatologist with over 20 years of experience in ... She is a Supervisory Board member at AM-Pharma B.V. and previously served on the Board of Directors for ChemoCentryx, Inc. until its acquisition by Amgen ... Rita Jain. Director. Discover similar people. Luisa ...
Provention Bio Appoints Rita Jain, M.D., to Board of Directors
WebChemoCentryx (NASDAQ: CCXI) is a biopharmaceutical company focused on discovering, developing, and commercializing orally-administered therapeutics to treat autoimmune diseases, ... Celldex Therapeutics Appoints Rita Jain, M.D. to Board of Directors. Feb 13, 2024. Immunosuppressants Global Market Report 2024. WebRita Jain's email address r*****@chemocentryx.com Show email & phone number >>> Rocketreach finds email, ... Member Board Of Directors @ ChemoCentryx; CMO @ Akebia … ios 7 math scanner
ChemoCentryx Company Profile Management and Employees …
WebFeb 16, 2024 · Earlier in her career, Dr. Jain served as a faculty member at North Shore University Hospital in New York. Dr. Jain currently serves as a member of the Board of … WebApr 6, 2024 · Jain has served as executive vice president and chief medical officer of ChemoCentryx, Inc., chief medical officer of Immunovant, Inc. and prior to that, senior vice president and chief medical ... WebOct 11, 2024 · Ahead of the launch of its first product, ChemoCentryx (CCXI) has bolstered its executive team with the appointment of Rita I. Jain as the company’s new chief … on the slave ship